Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Vifor Pharma and ChemoCentryx expand kidney health alliance

Dec. 23, 2016

CFDA grants approval for clinical trials of fadanafil

Dec. 16, 2016

Third Rock Ventures launches Goldfinch Bio with a focus on therapies for kidney disease

Dec. 15, 2016

Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD

Dec. 14, 2016

Blisibimod BRIGHT-SC study demonstrates positive trends in the week 48 analysis

Dec. 9, 2016

Regulus unveils new drug development candidates

Dec. 9, 2016

Anti-APRIL monoclonal antibody developed at Visterra for IgA nephropathy

Dec. 7, 2016

Pharmalink's Nefecon earns orphan drug designation in E.U. for IgAN

Nov. 30, 2016

MonoSol files NDA with FDA for Tadalafil PharmFilm in the treatment of erectile dysfunction

Nov. 29, 2016

Enrollment completed in phase IIa study of Serodus' SER-150

Nov. 28, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...